| BALCX | FFTMX | BALCX / FFTMX | |
| Total Expense Ratio | 1.31 | 1.07 | 122% |
| Annual Report Gross Expense Ratio | 1.31 | 1.10 | 119% |
| Fund Existence | 25 years | 19 years | - |
| Gain YTD | 2.396 | 2.536 | 94% |
| Front Load | N/A | 4% | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 270B | 10.6B | 2,547% |
| Annual Yield % from dividends | 1.25 | 1.82 | 69% |
| Returns for 1 year | 10.51 | 9.89 | 106% |
| Returns for 3 years | 33.72 | 26.15 | 129% |
| Returns for 5 years | 31.49 | 14.20 | 222% |
| Returns for 10 years | 79.52 | 62.48 | 127% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HNMDX | 14.33 | 0.22 | +1.56% |
| Heartland Mid Cap Value Institutional | |||
| RTXMX | 14.39 | 0.22 | +1.55% |
| Russell Inv Tax-Managed Real Assets M | |||
| BDSAX | 21.02 | 0.04 | +0.19% |
| BlackRock Advantage Small Cap Core Inv A | |||
| RYBOX | 63.69 | -0.09 | -0.14% |
| Rydex Biotechnology A | |||
| CFNEX | 94.29 | -1.14 | -1.19% |
| American Funds Fundamental Invs 529E | |||